Signed in as:
filler@godaddy.com
RapidPulse Pivotal Clinical Trial
The pivotal study of RapidPulse® as a frontline approach for patients with acute ischemic stroke due to large vessel occlusions.
Study Objectives
Primary Effectiveness Endpoint
Key Secondary Effectiveness Endpoints
Primary Effectiveness Endpoint
Frontline mTICI ≥ 2b after up to 3 passes (without rescue) as assessed by independent core lab.
Primary Safety Endpoint
Key Secondary Effectiveness Endpoints
Primary Effectiveness Endpoint
Rate of symptomatic intracranial hemorrhage (sICH) at 24 hours post-thrombectomy as assessed by an independent Clinical Events Committee.
Key Secondary Effectiveness Endpoints
Key Secondary Effectiveness Endpoints
Key Secondary Effectiveness Endpoints
First Pass Reperfusion Effect (FPE) as defined by mTICI ≥ 2c after one reperfusion attempt as assessed by an independent Core lab.
90 day modified Rankin Scale (mRS).